Mansur, Rodrigo B <br/><br/>
Cognitive dysfunction and metabolic comorbidities in mood disorders: A repurposing opportunity for glucagon-like peptide 1 receptor agonists?  [electronic resource] 

 -  Neuropharmacology  07 2018 
 - 335-342 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1873-7064 
<br/><br/><label>Standard No.: </label>10.1016/j.neuropharm.2018.01.048  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cognitive Dysfunction--epidemiology<br/>Comorbidity<br/>Glucagon-Like Peptide-1 Receptor--metabolism<br/>Humans<br/>Metabolic Diseases--epidemiology<br/>Mood Disorders--epidemiology<br/>Glucagon-Like Peptide-1 Receptor Agonists